Tesamorelin Acetate Handling & Reconstitution Protocol

Tesamorelin Acetate is a synthetic analogue of human growth-hormone-releasing factor (hGRF) that requires careful reconstitution, handling, and storage to preserve its biological activity in research applications.

Product Name

Tesamorelin Acetate

SKU

rp175272

Compound Class

Synthetic GHRH analogue (peptide)

Recommended Solvent

Sterile water or aqueous buffer (e.g., PBS, pH 7.4) for initial reconstitution

Storage Condition (lyophilised)

-20 °C or below, protected from moisture and light

Storage Condition (reconstituted)

2–8 °C for short-term (≤48 h); aliquot and store at -80 °C for longer periods

Materials and Safety Precautions

Before beginning, gather the following materials: Tesamorelin Acetate lyophilised powder (SKU rp175272), sterile water for injection or appropriate aqueous buffer (e.g., phosphate-buffered saline, pH 7.4), low-binding microcentrifuge tubes, sterile syringes and needles (or pipettes), ice bath, and a calibrated analytical balance or concentration-verification assay reagents.

Safety: Tesamorelin Acetate is a research reagent intended for in vitro or properly approved in vivo studies only. Wear appropriate personal protective equipment (PPE) including nitrile gloves, a lab coat, and eye protection. Avoid inhalation of the lyophilised powder. Consult the Safety Data Sheet (SDS) prior to use. Dispose of all biological and chemical waste according to your institutional regulations.

Note: This product is not approved for human therapeutic use outside of appropriately authorised clinical settings. For research use only (RUO).

Reconstitution Procedure

Step 1 – Equilibration: Remove the vial of lyophilised Tesamorelin Acetate (rp175272) from -20 °C storage and allow it to equilibrate to room temperature (18–25 °C) for approximately 10–15 minutes before opening. This prevents condensation from entering the vial and degrading the peptide.

Step 2 – Solvent preparation: Prepare sterile reconstitution solvent (sterile water for injection or PBS, pH 7.4). For working concentrations commonly used in research, a stock solution of 1 mg/mL is recommended as a starting point, but the target concentration should be determined based on the specific assay requirements.

Step 3 – Addition of solvent: Using a sterile syringe or pipette, slowly add the calculated volume of solvent to the inner wall of the vial rather than directly onto the lyophilised cake. This gentle addition minimises foaming and peptide aggregation.

Step 4 – Dissolution: Gently swirl or rotate the vial to dissolve the peptide completely. Do not vortex; vigorous agitation can cause peptide degradation and aggregation. If the powder does not dissolve readily, allow the vial to sit at room temperature for a further 5 minutes and gently swirl again.

Step 5 – Clarification check: Visually inspect the reconstituted solution. It should appear as a clear, colourless to pale-yellow solution free from visible particles. If turbidity or particulates are present, do not use; discard and consult the supplier.

Step 6 – Aliquoting: Transfer the reconstituted solution into pre-labelled, sterile, low-binding microcentrifuge tubes in single-use aliquots to avoid repeated freeze-thaw cycles, which degrade peptide integrity.

Storage and Stability Guidelines

Lyophilised powder: Store at -20 °C or below in a dry, dark environment. The lyophilised form offers significantly greater stability than reconstituted solutions. When stored under recommended conditions, the lyophilised powder is stable until the expiry date printed on the vial label.

Reconstituted solution: Use within 48 hours if stored at 2–8 °C. For longer-term storage, aliquot into single-use volumes and store at -80 °C. Avoid more than two freeze-thaw cycles, as this progressively degrades peptide potency and purity.

General precautions: Always keep the vial tightly sealed when not in use. Protect from light and moisture at all times. Do not store near strong oxidising agents or at temperatures above 25 °C for extended periods. Label all aliquots with compound name, concentration, date of reconstitution, and preparer's initials.

Stability indicator: A significant colour change (e.g., to yellow-brown) or visible precipitation in the reconstituted solution may indicate degradation. Discard any suspect material and note the lot number for quality reporting.

Quality Control and Verification

Purity assessment: Tesamorelin Acetate (rp175272) supplied by Aladdin Scientific is subject to quality control testing prior to release. Researchers should retain the Certificate of Analysis (CoA) supplied with the product, which provides purity, identity, and lot-specific data.

Concentration verification: After reconstitution, researchers may verify peptide concentration using UV absorbance (measuring absorbance at 280 nm if aromatic residues are present) or a validated peptide quantification assay such as BCA or a specific HPLC method. Note that Tesamorelin's extinction coefficient should be confirmed from the CoA or published literature before applying UV-based methods.

Biological activity confirmation: Where critical to the study, confirm bioactivity using an appropriate cell-based or biochemical assay (e.g., measuring GH release from pituitary cell models). Retain internal records of each lot's performance for traceability.

Documentation: Record lot number, date received, date of reconstitution, storage conditions, and all quality-check results in a laboratory notebook or electronic laboratory information management system (LIMS) for full traceability and GLP compliance where required.

Troubleshooting Common Issues

Problem: Incomplete dissolution. Ensure solvent is at room temperature before addition; allow more equilibration time. Check that the volume of solvent added is sufficient for the mass of peptide. If dissolution remains incomplete, briefly warm to 30–37 °C in a water bath and gently swirl; avoid temperatures above 40 °C.

Problem: Visible aggregation or precipitation after storage. This may indicate freeze-thaw damage or exposure to inappropriate temperatures. Discard the affected aliquot. Review storage records to identify any temperature excursions and report the lot number to Aladdin Scientific for investigation.

Problem: Lower-than-expected biological activity. Verify reconstituted concentration independently. Confirm that the assay system and positive controls are performing correctly. Consider whether the peptide was exposed to repeated freeze-thaw cycles or prolonged storage above -20 °C. Contact Aladdin Scientific technical support referencing lot number and CoA.

Problem: Turbid solution immediately after reconstitution. Ensure the correct solvent pH and ionic strength are being used. Some peptides are sensitive to pH extremes; adjust buffer pH to 7.0–7.4 and retry. Filter through a 0.22 µm low-protein-binding membrane if required for downstream assays, noting potential yield loss.

Frequently asked questions

What is the recommended solvent for reconstituting Tesamorelin Acetate?

Sterile water for injection or a physiologically compatible aqueous buffer such as phosphate-buffered saline (PBS) at pH 7.4 is recommended for reconstituting Tesamorelin Acetate. Avoid organic solvents, which may denature the peptide. Always consult the Certificate of Analysis supplied with your specific lot for any additional solubility guidance.

How should reconstituted Tesamorelin Acetate solution be stored?

Reconstituted Tesamorelin Acetate should be used within 48 hours when stored at 2–8 °C. For longer-term storage, aliquot into single-use volumes in low-binding tubes and store at -80 °C. Limit freeze-thaw cycles to no more than two to maintain peptide integrity and biological activity.

How can I confirm the biological activity of Tesamorelin Acetate after reconstitution?

Biological activity can be assessed using an appropriate cell-based assay, such as measuring growth hormone (GH) secretion from pituitary cell models stimulated with Tesamorelin Acetate. Researchers should include validated positive and negative controls in every assay run. The Certificate of Analysis provided by Aladdin Scientific should also specify any lot-specific activity data available.

Why should I avoid vortexing when dissolving Tesamorelin Acetate?

Vigorous agitation such as vortexing can introduce air-water interfaces that promote peptide unfolding, aggregation, and degradation, reducing both purity and biological activity. Gentle swirling or rotation is sufficient to dissolve the lyophilised peptide without compromising its structural integrity.

Is Tesamorelin Acetate (rp175272) suitable for in vivo studies?

Tesamorelin Acetate (rp175272) from Aladdin Scientific is labelled for research use only (RUO). Use in any in vivo study must comply with all applicable institutional, ethical, and regulatory requirements. Researchers are responsible for ensuring appropriate approvals (e.g., IACUC or equivalent) are in place before conducting animal studies.

References

1. Falutz J, et al. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension. Journal of Acquired Immune Deficiency Syndromes. 2010.
2. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism. 2006.
3. Aladdin Scientific. Certificate of Analysis – Tesamorelin Acetate (rp175272). Internal QC document.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.